Caricamento...
Erlotinib for Progressive Vestibular Schwannoma in Neurofibromatosis 2 Patients
In vitro treatment of Nf2-deficient cells with epidermal growth factor receptor (EGFR) inhibitors can inhibit cellular proliferation. We retrospectively assessed the effect of erlotinib (150 mg daily) on eleven consecutive NF2 patients with progressive VS who were poor candidates for standard therap...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2010
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4030413/ https://ncbi.nlm.nih.gov/pubmed/20736812 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MAO.0b013e3181eb328a |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|